SCHEMBL66840

SCHEMBL66840

COCC(O)C(C)N(C)C

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.55
PIK3CD O00329 1/20 0.33
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27383307 0.74 HSD17B10 (0.35) HSD17B10
SCHEMBL4919959 0.74 HSD17B10 (0.35) HSD17B10
SCHEMBL7971977 0.74 HSD17B10 (0.35) HSD17B10
SCHEMBL10297737 0.73
SCHEMBL12869038 0.73
SCHEMBL2669458 0.73
SCHEMBL12869035 0.73
SCHEMBL4190791 0.73
SCHEMBL10047659 0.73
SCHEMBL1932967 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129426-B2 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2012-03-06 US disclosed
US-20090298881-A1 Water-Soluble Artemisinin Derivatives, Their Preparation Methods, the Pharmaceutical Compositions and the Use Thereof JIANGSU ZUOYOU MEDICINE CO., LTD. (CN) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298881-A1 Water-Soluble Artemisinin Derivatives, Their Preparation Methods, the Pharmaceutical Compositions and the Use Thereof NFATC1, THPO, SQLE SPHK1 841/4885PIK3CD 1273/4885KDM4E 3498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.